NLNK - NewLink Genetics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
705
1,206
390
35,768
68,501
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
68,501
Operating Expenses
Research Development
23,186
45,694
69,866
93,300
71,414
Selling General and Administrative
24,910
29,218
31,726
33,226
30,689
Total Operating Expenses
48,096
63,644
73,271
126,526
102,103
Operating Income or Loss
-47,391
-62,438
-72,881
-90,758
-33,602
Interest Expense
51
52
119
22
105
Total Other Income/Expenses Net
-156
-102
-126
32
-41
Income Before Tax
-45,264
-60,563
-72,510
-90,511
-33,643
Income Tax Expense
23
-6,968
-559
-5,356
6,738
Income from Continuing Operations
-45,287
-53,595
-71,951
-85,155
-40,381
Net Income
-45,287
-53,595
-71,951
-85,155
-40,381
Net Income available to common shareholders
-45,287
-53,595
-71,951
-85,155
-40,381
Reported EPS
Basic
-
-1.44
-2.30
-2.94
-1.41
Diluted
-
-1.44
-2.30
-2.94
-1.41
Weighted average shares outstanding
Basic
-
37,191
31,304
28,979
28,587
Diluted
-
37,191
31,304
28,979
28,587
EBITDA
-
-59,366
-70,984
-84,447
-33,602